{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:28:25Z","timestamp":1784050105727,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.puhe.2018.10.015","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T01:29:12Z","timestamp":1547774952000},"page":"136-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Systematic review of the evidence on the epidemiology of herpes zoster: incidence in\u00a0the\u00a0general population and specific subpopulations\u00a0in Spain"],"prefix":"10.1016","volume":"167","author":[{"given":"M.","family":"Mareque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Oyag\u00fcez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Morano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2018.10.015_bib1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","article-title":"Varicella zoster vaccine for the prevention of herpes zoster","volume":"356","author":"Kimberlin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.puhe.2018.10.015_bib2","series-title":"Viral infections of humans","first-page":"659","article-title":"Varicella-herpes zoster virus","author":"Weller","year":"1989"},{"key":"10.1016\/j.puhe.2018.10.015_bib3","first-page":"93","article-title":"Varicella-zoster virus: prospects for control","volume":"10","author":"Gershon","year":"1995","journal-title":"Adv Pediatr Infect Dis"},{"key":"10.1016\/j.puhe.2018.10.015_bib4","series-title":"UpToDate","article-title":"Clinical manifestations of varicella-zoster virus infection: herpes zoster","author":"Albrecht","year":"2016"},{"issue":"5","key":"10.1016\/j.puhe.2018.10.015_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1590\/S1135-57272009000500012","article-title":"Epidemiolog\u00eda de la varicela en Espa\u00f1a en los periodos pre y post vacunaci\u00f3n. [Epidemiology of varicella in Spain pre-and post-vaccination periods]","volume":"83","author":"Pe\u00f1a-Rey","year":"2009","journal-title":"Rev Esp Salud Publica"},{"issue":"3 Suppl","key":"10.1016\/j.puhe.2018.10.015_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/erv.10.30","article-title":"Herpes zoster an postherpetic neuralgia","volume":"9","author":"Johnson","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.puhe.2018.10.015_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Clinical Practice: herpes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.puhe.2018.10.015_bib8","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/320169","article-title":"Herpes zoster in older adults","volume":"32","author":"Schmader","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2018.10.015_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","article-title":"What does epidemiology tell us about risk factors for herpes zoster?","volume":"4","author":"Thomas","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.puhe.2018.10.015_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-9-55","article-title":"Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004)","volume":"9","author":"Gil","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.puhe.2018.10.015_bib11","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.puhe.2018.10.015_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1533-2500.2010.00432.x","article-title":"Herpes zoster pain, postherpetic neuralgia, and quality of life in the elderly","volume":"11","author":"Pickering","year":"2011","journal-title":"Pain Pract"},{"issue":"2","key":"10.1016\/j.puhe.2018.10.015_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.pain.2011.10.026","article-title":"Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice","volume":"153","author":"Bouhassira","year":"2012","journal-title":"Pain"},{"issue":"7264","key":"10.1016\/j.puhe.2018.10.015_bib14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.321.7264.794","article-title":"Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up","volume":"321","author":"Helgason","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.puhe.2018.10.015_bib15","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.jaad.2007.08.046","article-title":"Herpes zoster: epidemiology, natural history, and common complications","volume":"57","author":"Weinberg","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"16","key":"10.1016\/j.puhe.2018.10.015_bib16","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1503\/cmaj.091711","article-title":"The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study","volume":"182","author":"Drolet","year":"2010","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.puhe.2018.10.015_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10389-011-0481-8","article-title":"The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries","volume":"20","author":"Lukas","year":"2012","journal-title":"Z Gesundh Wiss"},{"key":"10.1016\/j.puhe.2018.10.015_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-13-170","article-title":"Similar herpes zoster incidence across Europe: results from a systematic literature review","volume":"13","author":"Pinchinat","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.puhe.2018.10.015_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00128071-200506050-00005","article-title":"Current management of herpes zoster: the European view","volume":"6","author":"Volpi","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.puhe.2018.10.015_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/1471-2334-13-463","article-title":"Herpes zoster surveillance using electronic databases in the Valencian Community (Spain)","volume":"13","author":"Morant-Talamante","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.puhe.2018.10.015_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1600-6143.2003.00287.x","article-title":"Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era","volume":"4","author":"Gourishankar","year":"2004","journal-title":"Am J Transplant"},{"issue":"RR-5","key":"10.1016\/j.puhe.2018.10.015_bib22","first-page":"1","article-title":"Advisory committee on immunization practices (ACIP) centers for disease control and prevention (CDC). Prevention of herpes zoster: recommendations of the advisory committee on practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.puhe.2018.10.015_bib23","series-title":"Dolor en el herpes z\u00f3ster: prevenci\u00f3n y tratamiento","author":"Calvo-Mosquera","year":"2016"},{"issue":"4","key":"10.1016\/j.puhe.2018.10.015_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s15010-014-0645-x","article-title":"Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997\u20132006","volume":"42","author":"Guignard","year":"2014","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.puhe.2018.10.015_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu049","article-title":"Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States","volume":"1","author":"Suaya","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.puhe.2018.10.015_bib26","doi-asserted-by":"crossref","first-page":"g2911","DOI":"10.1136\/bmj.g2911","article-title":"Quantification of risk factors for herpes zoster: population based case-control study","volume":"348","author":"Forbes","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.puhe.2018.10.015_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0001-7310(06)73360-9","article-title":"Actualizaci\u00f3n en el tratamiento del herpes z\u00f3ster","volume":"97","author":"Espa\u00f1a","year":"2006","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.puhe.2018.10.015_bib28","series-title":"Ficha t\u00e9cnica de ZOSTAVAX\u00ae","author":"Agencia Europea de Medicamentos","year":"2011"},{"issue":"6","key":"10.1016\/j.puhe.2018.10.015_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","article-title":"Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory","volume":"5","author":"Coplan","year":"2004","journal-title":"J Pain"},{"issue":"2","key":"10.1016\/j.puhe.2018.10.015_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.puhe.2018.10.015_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001420","article-title":"Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study","volume":"10","author":"Langan","year":"2013","journal-title":"PLoS Med"},{"issue":"22","key":"10.1016\/j.puhe.2018.10.015_bib32","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.puhe.2018.10.015_bib33","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 Years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.puhe.2018.10.015_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"10 Suppl.1","key":"10.1016\/j.puhe.2018.10.015_bib35","article-title":"Dermatologicals manifestations induced by tumor necrosis factor antagonists therapy in rheumatic diseases. Incidence rate in BIOBADASER 2.0 registry","volume":"63","author":"Miguel","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.puhe.2018.10.015_bib36","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1136\/ard.2009.125658","article-title":"Incidence and risk of hospitalisation due to singles and chickenpox in patients with rheumatic diseases treated with TNF antagonists","volume":"69","author":"Garc\u00eda-Doval","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.puhe.2018.10.015_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2296-11-33","article-title":"Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain)","volume":"11","author":"Cebri\u00e1n-Cuenca","year":"2010","journal-title":"BMC Fam Pract"},{"issue":"SE2","key":"10.1016\/j.puhe.2018.10.015_bib38","first-page":"1","article-title":"Estimaci\u00f3n de la incidencia de herpes zoster en la Comunidad Valenciana a partir de 2 m\u00e9todos","volume":"24","author":"Guti\u00e9rrez-Gimeno","year":"2010","journal-title":"Gac Sanit"},{"issue":"SE2","key":"10.1016\/j.puhe.2018.10.015_bib39","first-page":"1","article-title":"Incidencia de herpes zoster atendida en atenci\u00f3n primaria en la Comunidad Valenciana (2007\u20132009)","volume":"24","author":"Guti\u00e9rrez-Gimeno","year":"2010","journal-title":"Gac Sanit"},{"issue":"Suppl 1","key":"10.1016\/j.puhe.2018.10.015_bib40","first-page":"S176","article-title":"Herpes zoster and diabetes: more and more","volume":"7","author":"Mu\u00f1oz-Quiles","year":"2016","journal-title":"Eur Geriatr Med"},{"issue":"7","key":"10.1016\/j.puhe.2018.10.015_bib41","doi-asserted-by":"crossref","first-page":"A603","DOI":"10.1016\/j.jval.2016.09.1480","article-title":"Herpes zoster-associated resources consumption in chronic obstructive pulmonary disease patients","volume":"19","author":"Mu\u00f1oz-Quiles","year":"2016","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.puhe.2018.10.015_bib42","first-page":"495","article-title":"Long-term acyclovir prophylaxis for prevention of varicela zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia","volume":"10","author":"Sempere","year":"1992","journal-title":"Bone Marrow Transplant"},{"issue":"S","key":"10.1016\/j.puhe.2018.10.015_bib43","first-page":"I","article-title":"Herpes z\u00f3ster. Primer a\u00f1o de vigilancia epidemiol\u00f3gica","volume":"29","author":"Fern\u00e1ndez","year":"2015","journal-title":"Gac Sanit"},{"issue":"SE2","key":"10.1016\/j.puhe.2018.10.015_bib44","first-page":"1","article-title":"Incidencia de herpes zoster en la Comunidad de Madrid, a\u00f1os 2001\u20132010","volume":"25","author":"Guti\u00e9rrez","year":"2011","journal-title":"Gac Sanit"},{"issue":"3","key":"10.1016\/j.puhe.2018.10.015_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MD.0b013e3181dfa59c","article-title":"Infectious and non-infectious neurologic complications in heart transplant recipients","volume":"89","author":"Mu\u00f1oz","year":"2010","journal-title":"Medicine (Baltim)"},{"issue":"8","key":"10.1016\/j.puhe.2018.10.015_bib46","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.transproceed.2006.08.060","article-title":"Varicella infection in adult renal allograft recipients: experience at one center","volume":"38","author":"Rodriguez-Moreno","year":"2006","journal-title":"Transplant Proc"},{"issue":"SE3","key":"10.1016\/j.puhe.2018.10.015_bib47","first-page":"1","article-title":"Evoluci\u00f3n de la incidencia de herpes zoster en la Comunidad de Madrid en los 5 a\u00f1os posteriores a la introducci\u00f3n de la vacuna frente a varicela (2007\u20132011)","volume":"26","author":"Cabrera Miranda","year":"2012","journal-title":"Gac Sanit"},{"issue":"6","key":"10.1016\/j.puhe.2018.10.015_bib48","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.4161\/hv.28620","article-title":"Sociodemographic characteristics and Chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain)","volume":"10","author":"Esteban-Vasallo","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.puhe.2018.10.015_bib49","series-title":"Regional epidemiological report of Madrid","year":"2014"},{"issue":"4","key":"10.1016\/j.puhe.2018.10.015_bib50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10096-008-0628-x","article-title":"Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention","volume":"28","author":"Garcia-Vidal","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.puhe.2018.10.015_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1576-9887(04)70364-7","article-title":"Situaci\u00f3n inmune frente a la varicela zoster antes y despu\u00e9s del trasplante de progenitores hematopoy\u00e9ticos","volume":"5","author":"Adell","year":"2004","journal-title":"Vacunas"},{"issue":"Espec Cong 1","key":"10.1016\/j.puhe.2018.10.015_bib52","first-page":"18","article-title":"Infecci\u00f3n del sistema nervioso central por el virus varicela-zoster en adultos","volume":"30","author":"Catal\u00e1n Eraso","year":"2012","journal-title":"Enfermedades Infecc Microbiol Cl\u00ednica"},{"issue":"1","key":"10.1016\/j.puhe.2018.10.015_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4321\/S1137-66272013000100006","article-title":"Herpes zoster incidence in diabetic patients","volume":"36","author":"Aldaz","year":"2013","journal-title":"An Sist Sanit Navar"},{"issue":"9","key":"10.1016\/j.puhe.2018.10.015_bib54","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/lt.20219","article-title":"Herpes zoster after liver transplantation: incidence, risk factors, and complications","volume":"10","author":"Herrero","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.puhe.2018.10.015_bib55","series-title":"Regional epidemiological report of Navarre","year":"2016"},{"issue":"SE","key":"10.1016\/j.puhe.2018.10.015_bib56","first-page":"1","article-title":"Situaci\u00f3n de la varicela y herpes zoster en la Comunidad Aut\u00f3noma del Pa\u00eds Vasco","volume":"24","author":"Sancho Mart\u00ednez","year":"2010","journal-title":"Gac Sanit"},{"issue":"Espec Cong 1","key":"10.1016\/j.puhe.2018.10.015_bib57","first-page":"18","article-title":"Infecci\u00f3n del sistema nervioso central por virus varicela-zoster en un \u00e1rea de Vizcaya (2000-2011): revisi\u00f3n de 50 casos","volume":"30","author":"L\u00f3pez Soria","year":"2012","journal-title":"Enfermedades Infecc Microbiol Cl\u00ednica"},{"issue":"S","key":"10.1016\/j.puhe.2018.10.015_bib58","first-page":"I","article-title":"Incidencia de herpes z\u00f3ster en pacientes atentidos en atenci\u00f3n primaria en Castilla y Le\u00f3n 2009\u20132014","volume":"29","author":"Ruiz Sope\u00f1a","year":"2015","journal-title":"Gac Sanit"},{"issue":"SE3","key":"10.1016\/j.puhe.2018.10.015_bib59","first-page":"1","article-title":"Incidencia de herpes zoster en Castilla y Le\u00f3n","volume":"26","author":"Vega","year":"2012","journal-title":"Gac Sanit"},{"issue":"1","key":"10.1016\/j.puhe.2018.10.015_bib60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2133.1998.02310.x","article-title":"Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse","volume":"139","author":"Mu\u00f1oz-P\u00e9rez","year":"1998","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.puhe.2018.10.015_bib61","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.transproceed.2006.08.039","article-title":"Efficacy and safety of monotherapy with mycophenolate mofetil in liver transplantation","volume":"38","author":"Jim\u00e9nez-P\u00e9rez","year":"2006","journal-title":"Transplant Proc"},{"issue":"SC","key":"10.1016\/j.puhe.2018.10.015_bib62","first-page":"I","article-title":"Incidencia y comorbilidad de herpes z\u00f3ster en Arag\u00f3n","volume":"30","author":"Cebollada","year":"2016","journal-title":"Gac Sanit"},{"key":"10.1016\/j.puhe.2018.10.015_bib63","series-title":"Regional epidemiological report of Aragon","year":"2016"},{"issue":"Espec Cong 1","key":"10.1016\/j.puhe.2018.10.015_bib64","first-page":"17","article-title":"Infecciones del sistema nervioso central producidas por el virus varicela-zoster","volume":"32","author":"Gilarranz","year":"2014","journal-title":"Enfermedades Infecc Microbiol Cl\u00ednica"},{"issue":"Espec Congr","key":"10.1016\/j.puhe.2018.10.015_bib65","first-page":"113","article-title":"Complicaciones neurol\u00f3gicas del virus varicela z\u00f3ster","volume":"25","author":"L\u00f3pez M\u00e9ndez","year":"2010","journal-title":"Neurologia"},{"key":"10.1016\/j.puhe.2018.10.015_bib66","series-title":"Regional epidemiological report of balearic Islands","year":"2016"},{"key":"10.1016\/j.puhe.2018.10.015_bib67","series-title":"Regional epidemiological report of Galicia","year":"2012"},{"issue":"Espec Cong 1","key":"10.1016\/j.puhe.2018.10.015_bib68","first-page":"15","article-title":"Incidencia del virus varicela z\u00f3ster en lesiones genitales","volume":"33","author":"\u00c1lvarez-Arg\u00fcelles","year":"2015","journal-title":"Enfermedades Infecc Microbiol Cl\u00ednica"},{"issue":"6","key":"10.1016\/j.puhe.2018.10.015_bib69","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.puhe.2018.10.015_bib70","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1080\/21645515.2017.1368600","article-title":"Risk and impact of herpes zoster on patients with diabetes: a population-based study, 2009\u20132014","volume":"13","author":"Mu\u00f1oz-Quiles","year":"2017","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.puhe.2018.10.015_bib71","series-title":"Royal-Decree Law 16\/2012, de 20 de abril, de medidas urgentes para garantizar la sostenibilidad del Sistema Nacional de Salud y mejorar la calidad y seguridad de sus prestaciones. BOE n\u00fam. 98, 24 de abril de","year":"2012"},{"issue":"6","key":"10.1016\/j.puhe.2018.10.015_bib72","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1590\/S1413-81232011000600016","article-title":"La sostenibilidad del Sistema Nacional de Salud en Espa\u00f1a","volume":"16","author":"Mart\u00edn","year":"2011","journal-title":"Ci\u00eancia Sa\u00fade Coletiva"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350618303433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350618303433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T21:37:48Z","timestamp":1565213868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350618303433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":72,"alternative-id":["S0033350618303433"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2018.10.015","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of the evidence on the epidemiology of herpes zoster: incidence in\u00a0the\u00a0general population and specific subpopulations\u00a0in Spain","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2018.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 GlaxoSmithKline Biologicals SA. Published by Elsevier Ltd on behalf of The Royal Society for Public Health.","name":"copyright","label":"Copyright"}]}}